Currently out of the existing stock ratings of Joseph Thome, 36 are a BUY (70.59%), 15 are a HOLD (29.41%).

Joseph Thome

Work Performance Price Targets & Ratings Chart

Analyst Joseph Thome, currently employed at TD COWEN, carries an average stock price target met ratio of 48.6% that have a potential upside of 26.33% achieved within 129 days. Previously, Joseph Thome worked at COWEN.

Joseph Thome’s has documented 103 price targets and ratings displayed on 17 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on UTHR, United Therapeutics at 26-Feb-2026.

Wall Street Analyst Joseph Thome

Analyst best performing recommendations are on PTCT (PTC THERAPEUTICS).
The best stock recommendation documented was for PTCT (PTC THERAPEUTICS) at 7/20/2020. The price target of $50 was fulfilled within 1 day with a profit of $3.29 (6.17%) receiving and performance score of 61.74.

Average potential price target upside

of $65.03 (168.33%) on AXSM (AXSOME THERAPEUTICS).
of $41.16 (16.12%) on UTHR (UNITED THERAPEUTICS).
of $12.64 (18.98%) on ITCI (INTRACELLULAR TH).

AXSM Axsome Therapeutics PTCT PTC Therapeutics UTHR United Therapeutics ESPR Esperion Therapeutics NTLA Intellia Therapeutics MRNS Marinus Pharmaceuticals TRDA Entrada Therapeutics EPZM Epizyme CERE Cerevel Therapeutics Holdings ALLK Allakos CMRX Chimerix ALKS Alkermes Plc ITCI Intracellular Th QURE Uniqure NV ADVM Adverum Biotechnologies AMLX Amylyx Pharmaceuticals ARDX Ardelyx

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Benjamin Burnett (WELLS FARGO)